Feed / STOK

Stoke Therapeutics, Inc.

STOK

Healthcare · 33.02 +12.2% today

Participation confirmed · construction unavailableMarket checked 19 Aug, 15:55 GMT-4

Jodie situation report

Stoke Therapeutics, Inc.'s move is being confirmed by its market group.

No new filing conclusion is available. 23 of 24 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 3 directly disclosed connections are confirming.

Company+12.2% todayVolume comparison unavailable
Market group23 of 24 activeRare Disease Biotech · active
Disclosed network0 of 3 confirmingNo filing-linked name is confirming now
What would change this read
  • At least 16 of 24 members remain active in the next snapshot.
  • Capital-flow agreement rises above 55%.
  • A filing-linked outsider such as XNCR begins moving with the group.

Invalidation: The live read weakens if participation falls to 8 of 24 members or fewer.

Watch this read

Who this business touches

The relationships behind STOK

Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.

Depends on

BIIBBiogen Inc.partnerMay 7, 2026

On February 14, 2025, we entered into a License and Collaboration Agreement (the “Biogen Agreement”) with Biogen International GmbH (“Biogen”) for the joint development and commercialization of zorevunersen and other compounds targeting the SCN1A gene (the “L…

ACADACADIA Pharmaceuticals Inc.partnerMar 16, 2026

In addition, although we intend to establish a sales organization if we are able to obtain approval to market any product candidates, we have entered into a strategic alliance with Biogen to develop and commercialize zorevunersen outside of North America (the…

Depended on by

ACADACADIA Pharmaceuticals Inc.partnerMay 7, 2026

In January 2022, the Company entered into a license and collaboration agreement with Stoke Therapeutics, Inc.

Filing peers

Companies whose filings use similar operating language.

Open the three relationships above to see Jodie’s filing proof. Pro unlocks 7 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →

What is moving around it

Live connections

STOK is currently a Early Follower in the organic co-movement group Rare Disease Biotech. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 3 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.